Fulcrum Therapeutics, Inc. (FULC)
10.75
-0.30
(-2.71%)
USD |
NASDAQ |
Jan 23, 16:00
10.74
-0.01
(-0.09%)
After-Hours: 20:00
Fulcrum Therapeutics Total Assets (Annual): 260.72M for Dec. 31, 2024
Total Assets (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Annual) Benchmarks
| Agios Pharmaceuticals, Inc. | 1.663B |
| Biogen, Inc. | 28.05B |
| CorMedix, Inc. | 118.85M |
| Apellis Pharmaceuticals, Inc. | 885.05M |
| NovaBay Pharmaceuticals, Inc. | 45.91M |